traditional gene-editing methods that depend on DNA cleavage, EPIREG™ presents a safer and groundbreaking therapeutic solution for individuals with chronic conditions, effectively addressing the safety issues linked to conventional gene editing. The company has pioneered two main technologies: epigenetic modulation and in-vivo lipid nanoparticle (LNP) delivery systems, which enhance the efficacy of gene therapies.